The Panel proceeded with full awareness of the limita- tions of the IC/BPS literature. These limita- tions include: poorly-defined patient groups or heterogeneous groups; small sample sizes; lack of placebo controls for many stud- ies, resulting in a likely over-estimation of efficacy; short...